These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteries. Azzam K; Garfinkel LI; Bal dit Sollier C; Cisse Thiam M; Drouet L Thromb Haemost; 1995 Feb; 73(2):318-23. PubMed ID: 7792749 [TBL] [Abstract][Full Text] [Related]
5. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor. Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505 [TBL] [Abstract][Full Text] [Related]
6. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics. Deckmyn H; Cauwenberghs N; Wu D; Depraetere H; Vanhoorelbeke K Verh K Acad Geneeskd Belg; 2005; 67(1):55-65. PubMed ID: 15828307 [TBL] [Abstract][Full Text] [Related]
7. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys. Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157 [TBL] [Abstract][Full Text] [Related]
8. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species. Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169 [TBL] [Abstract][Full Text] [Related]
9. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
10. TMVA, a novel GPIb-binding protein, significantly prevents platelet microthrombi formation and prolongs discordant cardiac xenograft survival. Chen G; Wei Q; Wang XM; Wang WY; Xiong YL; Chen S Xenotransplantation; 2004 Mar; 11(2):203-9. PubMed ID: 14962282 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic effect of a protein-type I class snake venom metalloproteinase, kistomin, is mediated by affecting glycoprotein Ib-von Willebrand factor interaction. Hsu CC; Wu WB; Chang YH; Kuo HL; Huang TF Mol Pharmacol; 2007 Oct; 72(4):984-92. PubMed ID: 17609416 [TBL] [Abstract][Full Text] [Related]
12. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Miyake T; Nomura S; Komiyama Y; Miyazaki Y; Kagawa H; Masuda M; Takahashi H; Fujimura Y; Ikeda Y; Fukuhara S Thromb Haemost; 1997 Aug; 78(2):902-9. PubMed ID: 9268193 [TBL] [Abstract][Full Text] [Related]
13. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727 [TBL] [Abstract][Full Text] [Related]
15. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion. Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713 [TBL] [Abstract][Full Text] [Related]
16. S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model. Gurevitz O; Eldar M; Skutelsky E; Tamarin I; Shenkman B; Eskaraev R; Castel D; Loscalzo J; Inbal A Thromb Haemost; 2000 Nov; 84(5):912-7. PubMed ID: 11127876 [TBL] [Abstract][Full Text] [Related]
17. Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex. Graham SS; Gonchoroff NJ; Miller JL Am J Clin Pathol; 2001 Jan; 115(1):144-7. PubMed ID: 11190800 [TBL] [Abstract][Full Text] [Related]
18. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. Kang M; Wilson L; Kermode JC Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030 [TBL] [Abstract][Full Text] [Related]
19. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates. Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780 [TBL] [Abstract][Full Text] [Related]
20. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]